Tessitore, Alessandro
Marano, Pietro
Modugno, Nicola
Pontieri, Francesco E.
Tambasco, Nicola
Canesi, Margherita
Latorre, Anna
Lopiano, Leonardo
Sensi, Mariachiara
Quatrale, Rocco
Solla, Paolo
Defazio, Giovanni
Melzi, Gabriella http://orcid.org/0000-0001-9944-3810
Costanzo, Anna Maria
Gualberti, Giuliana
di Luzio Paparatti, Umberto
Antonini, Angelo
Funding for this research was provided by:
AbbVie Srl
Article History
Received: 7 November 2017
Revised: 26 February 2018
Accepted: 27 February 2018
First Online: 7 March 2018
Change Date: 20 May 2020
Change Type: Correction
Change Details: The original version of this article unfortunately contained a mistake. In the Figure
Compliance with ethical standards
:
: A Antonini received compensation for consultancy and speaker activities from UCB, Boston Scientific, Boehringer Ingelheim, AbbVie, Neuroderm, Acadia and Zambon. He received research support from Mundipharma, Neureca Foundation, the Italian Ministry Research Grant RF-2010-2319551, and Horizon 2020 Program Grant N: 643706; G. Defazio received compensation for speaker Activision from Zambon and UN; N. Modugno has received compensation from AbbVie, Lundbeck, and UCB; N. Tambasco received speaker honoraria from Lundbeck and AbbVie; A. Tessitore received speaker and/or consulting honoraria from Lundbeck, AbbVie, UCB, Allergan, and Almirall; L. Lopiano, P. Marano, M. Sensi, and R. Quatrale have received honoraria for consulting services and symposia from AbbVie. P Solla has received honoraria for participation in advisory boards from AbbVie. A. Latorre and F.E. Pontieri have no conflict of interest to declare. G. Gualberti, G. Melzi, and U. di Luzio Paparatti are employees of AbbVie Italy and may own AbbVie stocks/options. AM. Costanzo was an AbbVie employee.